Login / Signup

Clinical outcome of breakthrough COVID-19 in multiple myeloma patients after three or more anti-SARS-CoV-2 vaccine doses: a single center analysis of 64 cases.

Nicola SgherzaPaola CurciRita RizziOlga BattistiAlberto PerfettoStefania WeiglAngela M V LaroccaMaria ChironnaSilvio TafuriPellegrino Musto
Published in: Annals of hematology (2023)
Keyphrases
  • sars cov
  • end stage renal disease
  • multiple myeloma
  • ejection fraction
  • coronavirus disease
  • newly diagnosed
  • chronic kidney disease
  • respiratory syndrome coronavirus
  • prognostic factors
  • patient reported outcomes